L690-0176 Screening compound: 3-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]-5-[2-(6-methyl-3,4-dihydro-2H-1,4-benzoxazin-4-yl)-2-oxoethyl]-3H,4H,5H-pyrimido[5,4-b]indol-4-one

L690-0176 Screening compound: 3-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]-5-[2-(6-methyl-3,4-dihydro-2H-1,4-benzoxazin-4-yl)-2-oxoethyl]-3H,4H,5H-pyrimido[5,4-b]indol-4-one
L690-0176 Screening compound: 3-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]-5-[2-(6-methyl-3,4-dihydro-2H-1,4-benzoxazin-4-yl)-2-oxoethyl]-3H,4H,5H-pyrimido[5,4-b]indol-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound L690-0176
3-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]-5-[2-(6-methyl-3,4-dihydro-2H-1,4-benzoxazin-4-yl)-2-oxoethyl]-3H,4H,5H-pyrimido[5,4-b]indol-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L690-0176

Molecular Formula

C25H22N6O4 (C25 H22 N6 O4)

Compound Name

3-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]-5-[2-(6-methyl-3,4-dihydro-2H-1,4-benzoxazin-4-yl)-2-oxoethyl]-3H,4H,5H-pyrimido[5,4-b]indol-4-one

IUPAC name

3-[(3-methyl-124-oxadiazol-5-yl)methyl]-5-[2-(6-methyl-34-dihydro-2H-14-benzoxazin-4-yl)-2-oxoethyl]-3H4H5H-pyrimido[54-b]indol-4-one

SMILES

Cc1noc(CN(C=Nc2c3n(CC(N4c(cc(C)cc5)c5OCC4)=O)c4c2cccc4)C3=O)n1

InChI

InChI=1S/C25H22N6O4/c1-15-7-8-20-19(11-15)30(9-10-34-20)22(32)13-31-18-6-4-3-5-17(18)23-24(31)25(33)29(14-26-23)12-21-27-16(2)28-35-21/h3-8,11,14H,9-10,12-13H2,1-2H3

InChI Key

SLACIZWXNLERJD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27469614

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

470.49

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.373

Distribution Coefficient, logD

2.373

Water Solubility, LogSw

-2.89

Polar Surface Area

79.164

Acid Dissociation Constant (pKa)

19.98

Base Dissociation Constant (pKb)

-1.20

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.00

L690-0176 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

Indole Derivatives (10091 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Structure:
  • Cyclic compounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L690-0176 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L690-0176?
Check Price and Availability of L690-0176, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L690-0176 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L690-0176
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L690-0176
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L690-0176 available by request